Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie.

Slides:



Advertisements
Similar presentations
Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Advertisements

Evaluation Questions Note: If not used for testing purposes, evaluation questions may be used in slide format inserted within or at the end of each module.
Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE.
Improving diagnosis TB laboratory strengthening.
W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers.
Prize for TB low-cost point of care rapid diagnostic test Pierre Chirac Médecins Sans Frontières, Paris, France Campaign for Access to Essential Medicines.
BACKGROUND LOW INCOME COUNTRY TUBERCULOSIS ♂>♀ A I M 1.Identify gender based differences in patients with Pulmonary Tb 2. Use this information to improve.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Nucleic Acid Amplification Test for Tuberculosis
Case discussion Michael Gardam University Health Network.
Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Washington D.C., USA, July 2012www.aids2012.org The value of universal TB screening with GeneXpert MTB/RIF in pre-ART patients in Harare L. Mupfumi.
Advocacy for TB POC Diagnostic Javid Syed TB/HIV 15th Core Group Meeting Nov 3-4, Geneva.
The ninth Technical Advisory Group and National TB Managers meeting
Diagnosis of TB.
Sensitivity, specificity and predictive values of symptoms to detect tuberculosis in the ZAMSTAR community based prevalence studies Peter Godfrey-Faussett.
Unit 5: IPT Isoniazid TB Preventive Therapy
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Southern Africa out of control Swaziland South Africa Namibia Botswana Zimbabwe Lesotho Zambia
Screening Sherine Shawky, MD, Dr.PH Assistant Professor Public Health King Abdulaziz University College of Medicine
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Module 4: From Suspect to Confirmed Case. Learning Objectives Explain why sputum microscopy is important Describe the process for confirming a TB suspect.
Tuberculosis Research of INA-RESPOND on Drug-resistant
1 Module OVERVIEW OF EXTERNAL QUALITY ASSESSMENT.
PatientAge INF-  on blood Culture 1 st evaluation 2 nd evaluation Days for positivization Identification DA1y 2mPOS13 daysM. tuberculosis EOA4y 3mIND.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
Dr K N Prasad Community Medicine
LOW RELIABILITY OF HOME-BASED DIAGNOSIS OF MALARIA IN A RURAL COMMUNITY IN WESTERN KENYA Rose Kakai (1), Josephine Nasimiyu (2), 1 Wilson Odero (1) 1 Maseno.
TUBERCULOSIS: THE LINKS WITH POVERTY Anthony D Harries The Union, Paris, France.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Tuberculosis Case Study Presenter Xoliswa Poswa TB Laboratory, NHLS/CMID.
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Integrated Management of Childhood Illnesses
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Dr Justin O’Grady. Zambia is a high burden TB and high HIV setting 44,154 TB cases notified in 2010 – incidence of 462/100,000 pop Approx 48% of pulmonary.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Optimization of Sputum Smear for Detection of TB: A Prospective Blinded Evaluation Joy Sarojini Michael, Kalaiselvan S, Peter Daley, Lois Armstrong, Shalini.
#AIDS2016 Intensified TB case-finding among PLHIV: diagnostic yield of Xpert MTB/RIF, Determine TB-LAM and liquid culture Fred Semitala,
Are we there yet? Spatial-temporal trend of mother to child HIV transmission in western Kenya, Anthony Waruru, Thomas Achia, Hellen Muttai, Lucy.
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
Philippe Glaziou Geneva, 12 October 2009
This is an archived document.
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
Presentation 10 Analysing results and defining cases
بسم الله الرحمن الرحيم.
Clinical consequences of new diagnostic tools for intestinal parasites
Ordering Sputum Cultures in Community Acquired Pneumonia
Utilization of Audio visual medium for conveying sputum collection instructions for tuberculosis diagnosis Presenter: Fred ORINA.
Presentation transcript:

Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie Githui 2, Francis Varaine 3, Andrew Ramsay 4,5, Philippe J Guerin 1 1 Epicentre, 2 Centre for Respiratory Diseases Research, Kenya Medical Research Institute, 3 Médecins Sans Frontières, 4 Liverpool School of Tropical Medicine, 5 TDR/WHO

TB diagnosis in peripheral health care centres  Ziehl-Neelsen Direct Smear microscopy  Only available tool in most settings  50% sensitivity  No new test expected in near future  Improvement of smear microscopy  Sputum collection (e.g. sputum induction)  Sputum processing (e.g. sputum concentration)  Staining and reading (e.g. fluorescence microscopy)

Rationale  Sodium hypochlorite (“household bleach”) with overnight sedimentation  Encouraging results  Could be implemented in any setting  Still no recommendations due to study limitations

 To evaluate the diagnostic yield and feasibility of microscopy after overnight bleach sedimentation in a peripheral laboratory  To compare direct smear microscopy and overnight bleach sedimentation  Smear-positive patient detection  Smear-positive specimen detection  To evaluate practical aspects of overnight bleach sedimentation Objective

 Population  Mathare, Nairobi  High HIV prevalence  > 15 years, pulmonary TB suspects (cough > 2 weeks)  Consecutive sampling  Procedure  Collection of 3 sputa in 2 days  Hot Ziehl Neelsen method Method

Bleach 3.5% Specimen liquifaction with bleach Overnight sedimentation on the bench Ziehl Neelsen microscopy on the sediment

 Case definitions  Smear-positive result: > 9 AFB/100 fields  Smear-positive patient  > 2 smear-positive results  > 1 smear-positive result  Analysis  McNemar test for comparison of matched data  Kappa coefficient for inter-reader and test-retest reliability (K >0.8: very good reliability) Method

Results: Trial profile 52 no sputum Total screened N= 788 Included N= 696 Analysed N= 644 patients Less than 15 years old =1 Impossibility to produce sputum = 7 Cough < 2 weeks = 20 ICF not signed =63 Other =1

Patients’ characteristics  Mean age: 32.5 years (SD 10.3)  Sex ratio, M/F: 0.8  Past TB history:121 (18.8%)  Intake of antibiotics in the last 2 weeks: 37 (5.7%)  Production of 3 sputa: 614 (95.3%)

 Definition of smear-positive patient : > 2 positive smears (N=621)  121 (19.5%) with bleach method compared to 105 (16.9%) with direct smear method, p=0.02  16 (15.2%) additional patients detected with bleach method  4 (3.8%) missed cases Smear-positive TB patient detection

 Definition of smear-positive patient: > 1 positive smear (N=644)  138 (21.4%) with bleach method compared to 120 (18.6%) with direct smear method, p=0.001  18 (15.0%) additional patients detected with bleach method  1 (0.8%) missed case Smear-positive patient detection

 Bleach on 2 first sputa versus direct smear microscopy on 3 sputa (N= 644)  Definition of smear-positive patient > 1 positive smear  133 (20.7%) with bleach method compared to 120 (18.6%) with direct smear method, p=0.01  18 (13.5%) additional patients detected with bleach method  5 (4.2%) missed cases Smear-positive patient detection

Smear-positive specimen detection

Practical aspects  Test reliability  Inter-observer Kappa 0.81 (95% CI )  Test-retest Kappa 0.93 (95% CI )  Mean duration of bleach sedimentation  Specimen bleaching: 18.6 min  Overnight sedimentation: 16.8 hours  Mean duration of Ziehl-Neelsen method  Smearing & drying: 52.9 min versus 21.4 min  Staining: 45.0 min versus 47.1 min  Reading: 3.5 min with both methods

Discussion  Study strengths  Prospective and controlled  Outpatient suspected TB cases in peripheral clinic  Standardised concentration method  Practical aspects  Reliability data  Study limitations Absence of comparison to the culture Gold Standard

Advantages & disadvantages of the bleach method  Advantages  Signifiant increase of TB patient detection  Good reliability  Ease of use  Inexpensive  Bleach readily available  Disadvantages  Risk of artefacts  Fragile smears  Delay in diagnosis  No standard bleach quality

Conclusions  Effective, simple and affordable  Further research needed  Best strategy based on cost-effectiveness analysis  Feasibility in routine program conditions  Overnight BS and fluorescence microscopy  Shorter sedimentation time

Acknowledgements  Médecins Sans Frontières, study promotor  Stéphanie Charrondière  Tom, Purity, Ali, Andrew and Lucy  The team in Blue House  The team in the Mycobacteriological Laboratory, KEMRI  The Kenyan National TB Control Program

Smear-positive TB patient detection